lithium carbonate has been researched along with idazoxan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Manji, HK; Ozerdem, A; Potter, WZ; Risinger, RC; Schmidt, ME | 1 |
2 other study(ies) available for lithium carbonate and idazoxan
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Chronic lithium administration enhances noradrenergic responses to intravenous administration of the alpha2 antagonist idazoxan in healthy volunteers.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Aged; Antimanic Agents; Chromatography, High Pressure Liquid; Female; Hemodynamics; Humans; Idazoxan; Injections, Intravenous; Lithium Carbonate; Male; Middle Aged; Norepinephrine; Regression Analysis; Sex Characteristics | 2004 |